Concert Pharmaceuticals Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
23.42 M |
Public Float |
22.11 M |
Concert Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3.13 |
Market Cap |
$290.07 M |
Shares Outstanding |
23.8 M |
Public Float |
19.43 M |
Address |
99 Hayden Avenue Lexington Massachusetts 02421 United States |
Employees | - |
Website | http://www.concertpharma.com |
Updated | 07/08/2019 |
Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. |